+29.1%
MRNA vs SYF
+154.1%
-125.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SYF | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -2.5% | +3.2% | +1.7% |
| 7D | -8.2% | -5.5% | -2.7% | -6.1% |
| 30D | +125.6% | -3.9% | +129.4% | +129.3% |
| 3M | +197.1% | +8.9% | +188.1% | +186.1% |
| 6M | +148.5% | +16.2% | +132.3% | +133.0% |
| YTD | +363.3% | -8.4% | +371.7% | +376.0% |
| 1Y | +462.0% | +2.6% | +459.4% | +450.7% |
| All | +29.1% | +154.1% | -125.0% | -4.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SYF.
Daily Out/Under-Performance
Portfolio return minus SYF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SYF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SYF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling